These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16513915

  • 1. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD, Wolter DJ, Wickman PA, Reisbig MD.
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [Abstract] [Full Text] [Related]

  • 2. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

  • 3. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A, Brown DL, Liu W, Kulawy RW, Deziel MR, Drusano GL.
    Antimicrob Agents Chemother; 2007 Nov 15; 51(11):3988-4000. PubMed ID: 17846144
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT, Tessier PR, Li C, Nightingale CH, Nicolau DP.
    Diagn Microbiol Infect Dis; 2007 Feb 15; 57(2):153-61. PubMed ID: 16930925
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
    Lister PD.
    Postgrad Med; 2008 Sep 15; 120(3 Suppl 1):46-52. PubMed ID: 18931471
    [Abstract] [Full Text] [Related]

  • 6. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L, De Vecchi E, Nicola L, Tocalli L, Gismondo MR.
    J Antimicrob Chemother; 2005 Aug 15; 56(2):353-9. PubMed ID: 15967767
    [Abstract] [Full Text] [Related]

  • 7. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P, Hocquet D, Jeannot K, Chavanet P, Plésiat P.
    J Antimicrob Chemother; 2005 Apr 15; 55(4):518-22. PubMed ID: 15722391
    [Abstract] [Full Text] [Related]

  • 8. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug 15; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 9. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep 15; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF, López JA, Camafeita E, Albar JP, Rojo F, Martínez JL.
    J Bacteriol; 2005 Feb 15; 187(4):1384-91. PubMed ID: 15687203
    [Abstract] [Full Text] [Related]

  • 11. [Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].
    Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P, Plésiat P.
    Pathol Biol (Paris); 2005 Feb 15; 53(8-9):495-9. PubMed ID: 16203109
    [Abstract] [Full Text] [Related]

  • 12. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar 15; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 13. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.
    J Antimicrob Chemother; 2013 Aug 15; 68(8):1772-80. PubMed ID: 23587654
    [Abstract] [Full Text] [Related]

  • 14. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH, Krikstopaityte V, Coote PJ.
    J Antimicrob Chemother; 2015 Aug 15; 70(8):2271-8. PubMed ID: 25921513
    [Abstract] [Full Text] [Related]

  • 15. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
    Yi MY, Wang PY, Huang HJ, Liu YC.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):457-62. PubMed ID: 16677571
    [Abstract] [Full Text] [Related]

  • 16. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul 21; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 17. Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
    Ozbek B, Otuk G.
    Chemotherapy; 2009 Jul 21; 55(6):446-50. PubMed ID: 19996590
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2006 Mar 21; 50(3):975-83. PubMed ID: 16495260
    [Abstract] [Full Text] [Related]

  • 19. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
    Farra A, Islam S, Strålfors A, Sörberg M, Wretlind B.
    Int J Antimicrob Agents; 2008 May 21; 31(5):427-33. PubMed ID: 18375104
    [Abstract] [Full Text] [Related]

  • 20. A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.
    Mesaros N, Glupczynski Y, Avrain L, Caceres NE, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2007 Mar 21; 59(3):378-86. PubMed ID: 17289770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.